Skip to main content
SpringerLink
Log in

Rheumatoid Arthritis

  • Chapter
  • First Online:
A Clinician's Pearls & Myths in Rheumatology

  • 1554 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ahern M, Lever JV, Cosh J. Complete heart block in rheumatoid arthritis. Ann Rheum Dis. 1983;42(4):389–97. https://doi.org/10.1136/ard.42.4.389.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81. https://doi.org/10.1002/art.27584.

    Article  PubMed  Google Scholar 

  • Amigues I, Tugcu A, Russo C, Giles JT, Morgenstein R, Zartoshti A, et al. Myocardial inflammation, measured using 18-fluorodeoxyglucose positron emission tomography with computed tomography, is associated with disease activity in rheumatoid arthritis. Arthritis Rheumatol. 2019;71:496–506.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Andres M, Vela P, Romera C. Marked improvement of lung rheumatoid nodules after treatment with tocilizumab. Rheumatology (Oxford). 2012;51(6):1132–4. https://doi.org/10.1093/rheumatology/ker455.

    Article  CAS  PubMed  Google Scholar 

  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24. https://doi.org/10.1002/art.1780310302.

    Article  CAS  PubMed  Google Scholar 

  • Aslam F, Bandeali SJ, Khan NA, Alam M. Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res. 2013;65:534–43.

    Google Scholar 

  • Atiqi S, Hooijberg F, Loeff FC, Rispens T, Wolbink GJ. Immunogenicity of TNF-inhibitors. Front Immunol. 2020;26(11):312. https://doi.org/10.3389/fimmu.2020.00312. PMID: 32174918; PMCID: PMC7055461.

    Article  CAS  Google Scholar 

  • Atzeni F, Talotta R, Masala IF, Gerardi MC, Casale R, Sarzi-Puttini P. Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents. Best Pract Res Clin Rheumatol. 2018;32(4):500–10. https://doi.org/10.1016/j.berh.2019.02.003.

    Article  PubMed  Google Scholar 

  • Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71(9):1524–9.

    PubMed  Google Scholar 

  • Baan H, Haagsma CJ, van de Laar MA. Corticosteroid injections reduce size of rheumatoid nodules. Clin Rheumatol. 2006;25(1):21–3. https://doi.org/10.1007/s10067-005-1098-5.

    Article  CAS  PubMed  Google Scholar 

  • Baghdad LR. Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: a systematic review and meta-analysis. PLoS One. 2020;15(7):e0235637.

    Google Scholar 

  • Balbir-Gurman A, Yigla M, Nahir AM, Braun-Moscovici Y. Rheumatoid pleural effusion. Semin Arthritis Rheum. 2006;35(6):368–78. https://doi.org/10.1016/j.semarthrit.2006.03.002.

    Article  PubMed  Google Scholar 

  • Barra L, Bykerk V, Pope JE, Haraoui BP, Hitchon CA, Thorne JC, et al. Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes. J Rheumatol. 2013;40(8):1259–67. https://doi.org/10.3899/jrheum.120736.

    Article  CAS  PubMed  Google Scholar 

  • Bérard A, et al. Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes. Ann Rheum Dis. 2018;77:500–9.

    PubMed  Google Scholar 

  • Bijlsma JWJ, Welsing PMJ, Woodworth TG, Middelink LM, Pethö-Schramm A, Bernasconi C, et al. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial. Lancet. 2016;388(10042):343–55.

    CAS  PubMed  Google Scholar 

  • Blanken AB, Agca R, van Sijl AM, Voskuyl AE, Boellaard R, Smulders YM, van der Laken CJ, Nurmohamed MT. Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment. Semin Arthritis Rheum. 2021;51(2):457–63. https://doi.org/10.1016/j.semarthrit.2021.03.008. Epub ahead of print. PMID: 33770536.

    Article  CAS  PubMed  Google Scholar 

  • Boleto G, Kanagaratnam K, Dramé M, et al. Safety of combination therapy with two bDMARDs in patients with rheumatoid arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2019;49:35–42.

    CAS  PubMed  Google Scholar 

  • Brown AK, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58:2958–67.

    CAS  PubMed  Google Scholar 

  • Burmester GR, Rigby WF, van Vollenhoven RF, Kay J, Rubbert-Roth A, Kelman A, Dimonaco S, Mitchell N. Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial. Ann Rheum Dis. 2016;75:1081–91.

    CAS  PubMed  Google Scholar 

  • Burmester GR, Lin Y, Patel R, van Adelsberg J, Mangan EK, et al. Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial. Ann Rheum Dis. 2017;76:840–7.

    CAS  PubMed  Google Scholar 

  • Bykerk V, Emery P. Delay in receiving rheumatology care leads to long-term harm. Arthritis Rheum. 2010;62(12):3519–21.

    PubMed  Google Scholar 

  • Chiou A, England BR, Sayles H, Thiele GM, Duryee MJ, Baker JF, Singh N, Cannon GW, Kerr GS, Reimold A, Gaffo A. Coexistent hyperuricemia and gout in rheumatoid arthritis: associations with comorbidities, disease activity, and mortality. Arthritis Care Res. 2020;72:950–8.

    CAS  Google Scholar 

  • Conaghan PG, et al. Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state. J Rheumatol. 2009;38:2039–44.

    Google Scholar 

  • Corrao S, Argano C, Pistone G, Messina S, Calvo L, Perticone F. Rheumatoid arthritis affects left ventricular mass: systematic review and meta-analysis. Eur J Intern Med. 2015;26:259–67.

    PubMed  Google Scholar 

  • Courvoisier DS, et al. The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries. Rheumatology (Oxford). 2021;60(2):820–8.

    CAS  PubMed  Google Scholar 

  • Crowson CS, Nicola PJ, Kremers HM, O’Fallon WM, Therneau TM, Jacobsen SJ, Roger VL, Ballman KV, Gabriel SE. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum. 2005;52:3039–44.

    PubMed  Google Scholar 

  • Curtis et al. Arthritis Rheumatol. 2021. https://doi.org/10.1002/art.41928. PMID: 34346564.

  • Dale J, Stirling A, Zhang R, Purves D, Foley J, Sambrook M, Conaghan PG, van der Heijde D, McConnachie A, McInnes IB, Porter D. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Ann Rheum Dis. 2016;75(6):1043–50.

    PubMed  Google Scholar 

  • Davis JM III, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum. 2008;58:2603–11.

    PubMed  PubMed Central  Google Scholar 

  • Day AL, Singh JA. Cardiovascular disease risk in older adults and elderly patients with rheumatoid arthritis: what role can disease-modifying antirheumatic drugs play in cardiovascular risk reduction? Drugs Aging. 2019;36(6):493–510. https://doi.org/10.1007/s40266-019-00653-0.

    Article  CAS  PubMed  Google Scholar 

  • de Jong PH, Hazes JM, Han HK, Huisman M, van Zeben D, van der Lubbe PA, et al. Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial. Ann Rheum Dis. 2014;73(7):1331–9.

    PubMed  Google Scholar 

  • de Man YA, Dolhain RJ, Hazes JM. Disease activity or remission of rheumatoid arthritis before, during and following pregnancy. Curr Opin Rheumatol. 2014;26(3):329–33. https://doi.org/10.1097/BOR.0000000000000045.

    Article  PubMed  Google Scholar 

  • De Stefano R, Frati E, Nargi F, Menza L. Efficacy of rituximab on pulmonary nodulosis occurring or increasing in patients with rheumatoid arthritis during anti-TNF-alpha therapy. Clin Exp Rheumatol. 2011;29(4):752–3.

    PubMed  Google Scholar 

  • Deane KD, Holers VM. Rheumatoid arthritis pathogenesis, prediction, and prevention: an emerging paradigm shift. Arthritis Rheumatol. 2021;73(2):181–93.

    PubMed  Google Scholar 

  • Deane K, Striebich C, Feser M, Demoruelle K, Moss L, Bemis E, Frazer-Abel A, Fleischer C, Sparks J, Solow E, James J, Guthridge J, Davis J, Graf J, Kay J, Danila M, Bridges L, Forbess L, O’Dell J, McMahon M, Grossman J, Horowitz D, Tiliakos A, Schiopu E, Fox D, Carlin J, Arriens C, Bykerk V, Jan R, Pioro M, Husni E, Fernandez-Pokorny A, Walker S, Booher S, Greenleaf M, Byron M, Keyes-Elstein L, Goldmuntz E, Holers M. Hydroxychloroquine does not prevent the future development of rheumatoid arthritis in a population with baseline high levels of antibodies to citrullinated protein antigens and absence of inflammatory arthritis: interim analysis of the StopRA Trial (Abstract 1604). Arthritis Rheumatol. 2022;74(Suppl 9).

    Google Scholar 

  • Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, Singh A, Pedersen RD, Koenig AS, Freundlich B. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet. 2008;372(9636):375–82. Epub 20080716. https://doi.org/10.1016/S0140-6736(08)61000-4. PubMed PMID: 18635256.

  • England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. 2018;361:k1036. https://doi.org/10.1136/bmj.k1036.

    Article  PubMed  PubMed Central  Google Scholar 

  • England BR, Tiong BK, Bergman MJ, Curtis JR, Kazi S, Mikuls TR, et al. 2019 Update of the American College of Rheumatology recommended rheumatoid arthritis disease activity measures. Arthritis Care Res (Hoboken). 2019;71(12):1540–55.

    PubMed  PubMed Central  Google Scholar 

  • Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011;63(3):573–86.

    PubMed  PubMed Central  Google Scholar 

  • Fleischmann R, Pangan AL, Song IH, Mysler E, et al. Upadacitinib versus placebo or adalimumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase iii, double-blind, randomized controlled trial. Arthritis Rheumatol. 2019;71:1788–800.

    CAS  PubMed  Google Scholar 

  • Floris A, Perra D, Cangemi I, Congia M, Chessa E, Angioni MM, et al. Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naive to DMARDs: results from a retrospective cohort study. Medicine (Baltimore). 2021;100(17):e25481. https://doi.org/10.1097/MD.0000000000025481.

    Article  CAS  PubMed  Google Scholar 

  • Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, Deane KD, Genovese M, Huston KK, Kerr G, Kremer J, Nakamura MC, Russell LA, Singh JA, Smith BJ, Sparks JA, Venkatachalam S, Weinblatt ME, Al-Gibbawi M, Baker JF, Barbour KE, Barton JL, Cappelli L, Chamseddine F, George M, Johnson SR, Kahale L, Karam BS, Khamis AM, Navarro-Millán I, Mirza R, Schwab P, Singh N, Turgunbaev M, Turner AS, Yaacoub S, Akl EA. 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2021;73(7):1108-23. Epub 20210608. https://doi.org/10.1002/art.41752. PubMed PMID: 34101376.

  • Fragoulis GE, et al. Neutropaenia in early rheumatoid arthritis: frequency, predicting factors, natural history and outcome. RMD Open. 2018;4:e000739.

    PubMed  PubMed Central  Google Scholar 

  • Fragoulis GE, et al. Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature. Rheumatology (Oxford). 2019a;58(11):1900–6.

    CAS  PubMed  Google Scholar 

  • Fragoulis GE, Nikiphorou E, Larsen J, Korsten P, Conway R. Methotrexate-associated pneumonitis and rheumatoid arthritis-interstitial lung disease: current concepts for the diagnosis and treatment. Front Med (Lausanne). 2019b;6:238. https://doi.org/10.3389/fmed.2019.00238.

    Article  PubMed  Google Scholar 

  • Gabay C, Emery P, van Vollenhoven R, Dikranian A, et al. Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial. Lancet. 2013;381:1541–50.

    CAS  PubMed  Google Scholar 

  • Gan RW, Bemis EA, Demoruelle MK, Striebich CC, Brake S, Feser ML, et al. The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anti-citrullinated protein antibody positive population. Rheumatology. 2017;56:2229–36.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Gautam S, Tolahunase M, Kumar U, Dada R. Impact of yoga based mind-body intervention on systemic inflammatory markers and co-morbid depression in active rheumatoid arthritis patients: a randomized controlled trial. Restor Neurol Neurosci. 2019;37(1):41–59.

    CAS  PubMed  Google Scholar 

  • Genovese MC, Cohen S, Moreland L, et al. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. Arthritis Rheum. 2004;50:1412–9.

    CAS  PubMed  Google Scholar 

  • Genovese MC, Kremer J, Zamani O, et al. Baricitinib in patients with refractory rheumatoid arthritis. N Engl J Med. 2016;374:1243–5240.

    CAS  PubMed  Google Scholar 

  • Genovese MC, Kalunian K, Gottenberg JE, et al. Effect of filgotinib vs placebo on clinical response in patients with moderate to severe rheumatoid arthritis refractory to disease-modifying antirheumatic drug therapy: the FINCH 2 randomized clinical trial. JAMA. 2019;322:315–25.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Gianfrancesco MA, Trupin L, Shiboski S, van der Laan M, Graf J, Imboden J, Yazdany J, Schmajuk G. Smoking is associated with higher disease activity in rheumatoid arthritis: a longitudinal study controlling for time-varying covariates. J Rheumatol. 2019;46:370–5.

    CAS  PubMed  Google Scholar 

  • Gottenberg JE, Brocq O, Perdriger A, Lassoued S, et al. Non-TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial. JAMA. 2016;316:1172–80.

    CAS  PubMed  Google Scholar 

  • Haavardsholm EA, Aga AB, Olsen IC, Lillegraven S, Hammer HB, Uhlig T, Fremstad H, Madland TM, Lexberg ÅS, Haukeland H, Rødevand E. Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial. BMJ. 2016;354:i4205.

    PubMed  PubMed Central  Google Scholar 

  • Hamann P, Holland R, Hyrich K, Pauling JD, Shaddick G, Nightingale A, McHugh N. Factors associated with sustained remission in rheumatoid arthritis in patients treated with anti-tumor necrosis factor. Arthritis Care Res (Hoboken). 2017;69:783–93.

    PubMed  Google Scholar 

  • Hamda B, et al. Rheumatoid nodule and complete heart block: diagnosis by transesophageal echocardiography. Ann Cardiol Angeiol (Paris). 2004;53:101–4.

    PubMed  Google Scholar 

  • Hammam N, Gheita TA. Impact of secondhand smoking on disease activity in women with rheumatoid arthritis. Clin Rheumatol. 2017;36:2415–20.

    PubMed  Google Scholar 

  • Hedström AK, Rönnelid J, Klareskog L, Alfredsson L. Complex relationships of smoking, HLA-DRB1 genes, and serologic profiles in patients with early rheumatoid arthritis: update from a Swedish population-based case-control study. Arthritis Rheumatol. 2019;71:1504–11.

    PubMed  PubMed Central  Google Scholar 

  • Hetland ML, Haavardsholm EA, Rudin A, Nordström D, Nurmohamed M, Gudbjornsson B, Lampa J, Hørslev-Petersen K, Uhlig T, Grondal G, Østergaard M, Heiberg MS, Twisk J, Lend K, Krabbe S, Hyldstrup LH, Lindqvist J, Hultgård Ekwall AK, Grøn KL, Kapetanovic M, Faustini F, Tuompo R, Lorenzen T, Cagnotto G, Baecklund E, Hendricks O, Vedder D, Sokka-Isler T, Husmark T, Ljoså MA, Brodin E, Ellingsen T, Söderbergh A, Rizk M, Olsson ÅR, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Laurberg TB, Bakland G, Olsen IC, van Vollenhoven R. NORD-STAR study group. Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial. BMJ. 2020;2(371):m4328. https://doi.org/10.1136/bmj.m4328.

    Article  Google Scholar 

  • Hewitt D, Cole J. Rheumatoid nodules without arthritis. Australas J Dermatol. 2005;46(2):93–6.

    PubMed  Google Scholar 

  • Hider SL, Tanveer W, Brownfield A, Mattey DL, Packham JC. Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic. Rheumatology. 2009;48(9):1152–4.

    PubMed  Google Scholar 

  • Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis. J Rheumatol. 2006;33:481–5.

    CAS  PubMed  Google Scholar 

  • Holers VM, Demoruelle MK, Kuhn KA, Buckner JH, Robinson WH, Okamoto Y, et al. Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nature Rev Rheum. 2018;14:542–57.

    Google Scholar 

  • Hotamisligil GS, et al. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542:177–85.

    CAS  PubMed  Google Scholar 

  • Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, Zink A, Buttgereit F. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis. 2009;68(7):1119–24.

    CAS  PubMed  Google Scholar 

  • Ibfelt EH, Jacobsen RK, Kopp TI, Cordtz RL, Jakobsen AS, Seersholm N, Shaker SB, Dreyer L. Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study. Rheumatology. 2021;60:346–52.

    CAS  PubMed  Google Scholar 

  • Ishikawa Y, Terao C. The impact of cigarette smoking on risk of rheumatoid arthritis: a narrative review. Cell. 2020;9(2):475. https://doi.org/10.3390/cells9020475.

    Article  CAS  Google Scholar 

  • Ishikawa Y, Ikari K, Hashimoto M, Ohmura K, Tanaka M, Ito H, Taniguchi A, Yamanaka H, Mimori T, Terao C. Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor. Ann Rheum Dis. 2019;78:1480–7.

    CAS  PubMed  Google Scholar 

  • Jethwa H, Lam S, Smith C, Giles I. Does rheumatoid arthritis really improve during pregnancy? A systematic review and metaanalysis. J Rheumatol. 2019;46(3):245–50.

    PubMed  Google Scholar 

  • Juge PA, Lee JS, Lau J, Kawano-Dourado L, Rojas Serrano J, Sebastiani M, et al. Methotrexate and rheumatoid arthritis associated interstitial lung disease. Eur Respir J. 2021;57(2):2000337. https://doi.org/10.1183/13993003.00337-2020.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Karlson EW, Deane KD. Environmental and gene-environment interactions and risk of rheumatoid arthritis. Rheum Dis Clin N Am. 2012;38:405–26.

    Google Scholar 

  • Kiely P, Busby AD, Nikiphorou E, Sullivan K, Walsh DA, Creamer P, Dixey J, Young A. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts. BMJ Open. 2019;9:e028466.

    PubMed  PubMed Central  Google Scholar 

  • Klareskog L, Malmstrom V, Lundberg K, Padyukov L, Alfredsson L. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol. 2011;23:92–8.

    CAS  PubMed  Google Scholar 

  • Krabben A, Stomp W, et al. Evaluation of magnetic resonance imaging-detected tenosynovitis in the hand and wrist in early arthritis. Arthritis Rheumatol. 2015;67:869–76.

    PubMed  Google Scholar 

  • Kremer JM, Rigby W, Singer NG, Birchwood C, Gill D, Reiss W, et al. Sustained response following discontinuation of methotrexate in patients with rheumatoid arthritis treated with subcutaneous tocilizumab: results from a randomized, controlled trial. Arthritis Rheumatol. 2018;70:1200–8.

    CAS  PubMed  Google Scholar 

  • Krijbolder, et al. Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burder (TREAT EARLER): a randomised, double-bline, placebo-controlled proof-of-concept trial. Lancet. 2022. https://doi.org/10.1016/S0140-6736(22)01193-X. PMID 35871815.

  • Kubo S, Nakayamada S, Nakano K, Hirata S, et al. Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching. Ann Rheum Dis. 2016;75:1321–7.

    CAS  PubMed  Google Scholar 

  • Kuriya B, Schieir O, Valois MF, et al. Prevalence and characteristics of metabolic syndrome differ in men and women with early rheumatoid arthritis. ACR Open Rheumatol. 2019;1(9):535–41.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lee EB, Fleischmann R, Hall S, Wilkinson B, Bradley JD, Gruben D, et al. Tofacitinib versus methotrexate in rheumatoid arthritis. N Engl J Med. 2014;19(370):2377–86.

    Google Scholar 

  • Li D, et al. Subcutaneous administration of methotrexate at high doses makes a better performance in the treatment of rheumatoid arthritis compared with oral administration of methotrexate: a systematic review and meta-analysis. Semin Arthritis Rheum. 2016;45:656–62.

    CAS  PubMed  Google Scholar 

  • Light RW. Pleural effusions. Med Clin North Am. 2011;95(6):1055–70. https://doi.org/10.1016/j.mcna.2011.08.005.

    Article  PubMed  Google Scholar 

  • Lal P, Su Z, Holweg CTJ, et al. Arthritis Rheum. 2011. https://doi.org/10.1002/art.30596. PMID: 22127691.

  • Loomba R, Liang TJ. Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions. Gastroenterology. 2017;152(6):1297–309. https://doi.org/10.1053/j.gastro.2017.02.009.

    Article  PubMed  Google Scholar 

  • Malmström V, Catrina AI, Klareskog L. The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat Rev Immunol. 2017;17:60–75.

    PubMed  Google Scholar 

  • Mangnus L, Schoones JW, van der Helm-van Mil AHM. What is the prevalence of MRI-detected inflammation and erosions in small joints in the general population? A collation and analysis of published data. RMD Open. 2015;1:e000005.

    PubMed  PubMed Central  Google Scholar 

  • Mangnus L, van Steenbergen HW, Reijnierse M, et al. Magnetic resonance imaging-detected features of inflammation and erosions in symptom-free persons from the general population. Arthritis Rheumatol. 2016;68:2593–602.

    CAS  PubMed  Google Scholar 

  • Mankia K, D’Agostino M-A, Rowbotham E, Hensor EM, Hunt L, Möller I, et al. MRI inflammation of the hand interosseous tendons occurs in anti-CCP-positive at-risk individuals and may precede the development of clinical synovitis. Ann Rheum Dis. 2019;78:781–6.

    PubMed  Google Scholar 

  • Mankia K, Emery P. Palindromic rheumatism as part of the rheumatoid arthritis continuum. Nat Rev Rheumatol. 2019. https://doi.org/10.1038/s41584-019-0308-5. PMID 31595059a.

  • Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF, American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016;123(6):1386–94. https://doi.org/10.1016/j.ophtha.2016.01.058.

    Article  PubMed  Google Scholar 

  • Matcham F, et al. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013;52:2136–48.

    PubMed  Google Scholar 

  • McKenna MC, Vaughan D, Bermingham N, Cronin S. Rheumatoid arthritis presenting as rheumatoid meningitis. BMJ Case Rep. 2019;12(1):bcr-2018-226649. https://doi.org/10.1136/bcr-2018-226649.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mease P, Charles-Schoeman C, Cohen S, Fallon L, Woolcott J, Yun H, Kremer J, Greenberg J, Malley W, Onofrei A, Kanik KS. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data. Ann Rheum Dis. 2020;79:1400–13.

    CAS  PubMed  Google Scholar 

  • Merdler-Rabinowicz R, Tiosano S, Comaneshter D, Cohen AD, Amital H. Comorbidity of gout and rheumatoid arthritis in a large population database. Clin Rheumatol. 2017;36:657–60.

    PubMed  Google Scholar 

  • Michelsen B, Kristianslund EK, Sexton J, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis. 2017;76(11):1906–10.

    PubMed  Google Scholar 

  • Møller-Bisgaard J, Boesen M, Christensen R, Stengaard-Pedersen K, Madsen OR. Effect of magnetic resonance imaging vs conventional treat-to-target strategies on disease activity remission and radiographic progression in rheumatoid arthritis: the IMAGINE-RA randomized clinical trial. JAMA. 2019;321:461–72.

    PubMed  PubMed Central  Google Scholar 

  • Moots RJ, Xavier RM, Mok CC, Rahman MU, Tsai WC, Al-Maini MH, et al. The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: results from a multinational, real-world clinical practice, non-interventional study. PLoS One. 2017;12(4):e0175207. https://doi.org/10.1371/journal.pone.0175207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moreland LW, Moreland LW, O’Dell JR, Paulus HE, Curtis JR, Bathon JM, St Clair EW, Bridges SL Jr, Zhang J, McVie T, Howard G, van der Heijde D, Cofield SS, TEAR Investigators. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheum. 2012 Sep;64(9):2824–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Myasoedova E, Crowson CS, Turesson C, Gabriel SE, Matteson EL. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study. J Rheumatol. 2011;38(6):983–9.

    PubMed  PubMed Central  Google Scholar 

  • Nagy G, Roodenrijs NMT, Welsing PM, Kedves M, Hamar A, van der Goes MC, Kent A, Bakkers M, Blaas E, Senolt L, Szekanecz Z, Choy E, Dougados M, Jacobs JW, Geenen R, Bijlsma HW, Zink A, Aletaha D, Schoneveld L, van Riel P, Gutermann L, Prior Y, Nikiphorou E, Ferraccioli G, Schett G, Hyrich KL, Mueller-Ladner U, Buch MH, McInnes IB, van der Heijde D, van Laar JM. EULAR definition of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis. 2021;80(1):31–5.

    PubMed  Google Scholar 

  • Nakamura T, Shiraishi N, Morikami Y, Fujii H, Kuratsu J. Systemic AA amyloidosis secondary to rheumatoid arthritis may be treatable but is still difficult to manage in daily clinical practice. Amyloid. 2019;26(Supp 1):123–4. https://doi.org/10.1080/13506129.2019.1582025.

    Article  PubMed  Google Scholar 

  • Nam JL, Villeneuve E, Hensor EM, Conaghan PG, Keen HI, Buch MH, et al. Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). Ann Rheum Dis. 2014;73(1):75–85.

    CAS  PubMed  Google Scholar 

  • Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum. 2005;52:412–20.

    PubMed  Google Scholar 

  • Nicola PJ, Crowson CS, Maradit-Kremers H, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum. 2006;54:60–7.

    PubMed  Google Scholar 

  • Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, Wordsworth PB, Neubauer S, Karamitsos TD. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging. 2015;8:526–36.

    PubMed  Google Scholar 

  • Nyhall-Wahlin BM, Petersson IF, Nilsson JA, Jacobsson LT, Turesson C, BARFOT Study Group. High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis. Rheumatology (Oxford). 2009;48(4):416–20. https://doi.org/10.1093/rheumatology/kep004.

    Article  CAS  PubMed  Google Scholar 

  • O’Dell JR, Haire CE, Erikson N, Drymalski W, Palmer W, Eckhoff PJ, Garwood V, Maloley P, Klassen LW, Wees S, Klein H, Moore GF. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med. 1996;334(20):1287−91. https://doi.org/10.1056/NEJM199605163342002. PubMed PMID: 8609945.

  • O’Dell JR, Mikuls TR, Taylor TH, et al. Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med. 2013;369:307–18.

    PubMed  Google Scholar 

  • Olaru L, Soong L, Dhillon S, Yacyshyn E. Coexistent rheumatoid arthritis and gout: a case series and review of the literature. Clin Rheumatol. 2017;36(12):2835–8. https://doi.org/10.1007/s10067-017-3856-6.

    Article  PubMed  Google Scholar 

  • Owlia MB, Newman K, Akhtari M. Felty’s syndrome, insights and updates. Open Rheumatol J. 2014;8:129–36. https://doi.org/10.2174/1874312901408010129.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ozen G, Pedro S, Michaud K. The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol. 2021;48(5):648–55. https://doi.org/10.3899/jrheum.200265.

    Article  PubMed  Google Scholar 

  • Park JK, Lee YJ, Shin K, Ha YJ, Lee EY, Song YW, Choi Y, Winthrop KL, Lee EB. Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial. Ann Rheum Dis. 2018;77:898–904.

    CAS  PubMed  Google Scholar 

  • Patatanian E, Thompson DF. A review of methotrexate-induced accelerated nodulosis. Pharmacotherapy. 2002;22(9):1157–62. https://doi.org/10.1592/phco.22.13.1157.33525.

    Article  CAS  PubMed  Google Scholar 

  • Plant MJ, Jones PW, Saklatvala J, Ollier WE, Dawes PT. Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study. J Rheumatol. 1998;25(3):417–26.

    CAS  PubMed  Google Scholar 

  • Plein S, Erhayiem B, Fent G, et al. Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naive, early rheumatoid arthritis. Ann Rheum Dis. 2020;79:1414–22.

    CAS  PubMed  Google Scholar 

  • Rau R, Herborn G, Menninger H, Blechschmidt J. Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients. Br J Rheumatol. 1997;36(3):345–52. https://doi.org/10.1093/rheumatology/36.3.345.

    Article  CAS  PubMed  Google Scholar 

  • Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J, Hua C. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2018;77:98–103.

    CAS  PubMed  Google Scholar 

  • Riches PL, Elherik FK, Dolan S, Unglaub F, Breusch SJ. Patient rated outcomes study into the surgical interventions available for the rheumatoid hand and wrist. Arch Orthop Trauma Surg. 2016;136(4):563–70. https://doi.org/10.1007/s00402-016-2412-1.

    Article  PubMed  Google Scholar 

  • Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, et al. Low-dose methotrexate for the prevention of atherosclerotic events. N Engl J Med. 2019;380(8):752–62.

    CAS  PubMed  Google Scholar 

  • Rogier C, Hayer S, van der Helm-van Mil A. Not only synovitis but also tenosynovitis needs to be considered: why it is time to update textbook images of rheumatoid arthritis. Ann Rheumdis Diseases. 2019;79(4):annrheumdis-2019-216350-2019-216350.

    Google Scholar 

  • Rosa JE, Garcia MV, Luissi A, Pierini F, Sabelli M, Mollerach F, et al. Rheumatoid arthritis patient’s journey: delay in diagnosis and treatment. J Clin Rheumatol. 2020;26(7S Suppl 2):S148–S52. https://doi.org/10.1097/RHU.0000000000001196.

    Article  PubMed  Google Scholar 

  • Rosenbaum JT, Costenbader KH, Desmarais J, Ginzler EM, Fett N, Goodman SM, et al. American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 joint statement on hydroxychloroquine use with respect to retinal toxicity. Arthritis Rheumatol. 2021;73(6):908–11. https://doi.org/10.1002/art.41683.

    Article  PubMed  Google Scholar 

  • Sautner J, Rintelen B, Leeb BF. Rituximab as effective treatment in a case of severe subcutaneous nodulosis in rheumatoid arthritis. Rheumatology (Oxford). 2013;52(8):1535–7. https://doi.org/10.1093/rheumatology/kes406.

    Article  PubMed  Google Scholar 

  • Schett G, Emery P, Tanaka Y, Burmester G, Pisetsky DS, Naredo E, et al. Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions. Ann Rheum Dis. 2016;75(8):1428–37. https://doi.org/10.1136/annrheumdis-2016-209201.

    Article  CAS  PubMed  Google Scholar 

  • Schiff M, Weinblatt ME, Valente R, van der Heijde D, et al. Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial. Ann Rheum Dis. 2014;73:86–94.

    CAS  PubMed  Google Scholar 

  • Schmidt TJ, Aviña-Zubieta JA, Sayre EC, et al. Cardiovascular disease prevention in rheumatoid arthritis: compliance with diabetes screening guidelines. J Rheumatol. 2018;45(10):1367–74.

    PubMed  Google Scholar 

  • Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3–15.

    PubMed  Google Scholar 

  • Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76:960–77.

    PubMed  Google Scholar 

  • Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79:685–99.

    CAS  PubMed  Google Scholar 

  • Sokolove J, Wagner CA, Lahey LJ, Sayles H, Duryee MJ, Reimold AM, Kerr G, Robinson WH, Cannon GW, Thiele GM, Mikuls TR. Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: a cross-sectional analysis of US veterans. Rheumatology. 2016;55:1969–77.

    PubMed  PubMed Central  Google Scholar 

  • Soukup T, Dosedel M, Nekvindova J, Antonin Kubena A, Tacheci I, Duintjer Tebbens J, et al. The plausible association of MTHFR and ADORA2A polymorphisms with nodules in rheumatoid arthritis patients treated with methotrexate. Pharmacogenet Genomics. 2017;27(2):43–50.

    CAS  PubMed  Google Scholar 

  • Sparks JA, He X, Huang J, Fletcher EA, Zaccardelli A, Friedlander HM, et al. Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study. Arthritis Rheumatol. 2019;71(9):1472–82. https://doi.org/10.1002/art.40904.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stevens E, Weinblatt ME, Massarotti E, et al. Safety of the zoster vaccine recombinant adjuvanted in rheumatoid arthritis and other systemic rheumatic disease patients: a single center’s experience with 400 patients. ACR Open Rheumatol. 2020;2:357–61.

    PubMed  PubMed Central  Google Scholar 

  • Stoffer MA, Schoels MM, Smolen JS, Aletaha D, Breedveld FC, Burmester G, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Ann Rheum Dis. 2016;75(1):16–22. https://doi.org/10.1136/annrheumdis-2015-207526.

    Article  PubMed  Google Scholar 

  • Symmons DP, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol. 2011;7:399.

    PubMed  Google Scholar 

  • Takeuchi T, Tanaka Y, Soen S, Yamanaka H, Yoneda T, Tanaka S, Nitta T, Okubo N, Genant HK, van der Heijde D. Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial. Ann Rheum Dis. 2019;78:899–907.

    CAS  PubMed  Google Scholar 

  • Taylor PC, Jain R. ‘The odd couple?’ – hardly. The emerging overlap between rheumatology and psychiatry. Rheumatology (Oxford). 2018;57(8):1313–5.

    PubMed  Google Scholar 

  • Taylor PC, Pope J. Treating to target or treating the patient in rheumatoid arthritis? Lancet Rheumatol. 2019;1:e8–10.

    Google Scholar 

  • Terslev L, Brahe CH, Hetland ML, Georgiadis S, Ellegaard K, Juul L, et al. Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission. Rheumatology (Oxford). 2021a;60(12):5549–59. https://doi.org/10.1093/rheumatology/keab276.

    Article  CAS  PubMed  Google Scholar 

  • Terslev L, Brahe CH, Ostergaard M, Fana V, Ammitzboll-Danielsen M, Moller T, et al. Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission. Arthritis Res Ther. 2021b;23(1):48. https://doi.org/10.1186/s13075-021-02426-w.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Thery C, Lekieffre J, Gosselin B, Warembourg H. Atrio-ventricular block in rheumatoid polyarthritis. Histological study of the his-Tawara system. Apropos of 2 cases. Arch Mal Coeur Vaiss. 1974;67(10):1181–91.

    CAS  PubMed  Google Scholar 

  • Tian Z, Mclaughlin J, Verma A, et al. The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Endocrinol Metab. 2021;10(2):125–31.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Trouw LA, Rispens T, Toes REM. Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis. Nat Rev Rheumatol. 2017;13:331–9.

    CAS  PubMed  Google Scholar 

  • Turesson C, Jacobsson LT. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol. 2004;33(2):65.

    CAS  PubMed  Google Scholar 

  • van Delft MAM, Huizinga TWJ. An overview of autoantibodies in rheumatoid arthritis. J Autoimmun. 2020;110:102392. https://doi.org/10.1016/j.jaut.2019.102392.

    Article  CAS  PubMed  Google Scholar 

  • van den Brandt S, Zbinden A, Baeton D, et al. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther. 2017;19:64.

    PubMed  PubMed Central  Google Scholar 

  • van der Heijde D, Strand V, Tanaka Y, Keystone E, Kremer J, Zerbini CAF, et al. Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: clinical efficacy, radiographic, and safety outcomes from a twenty-four-month, phase III study. Arthritis Rheumatol. 2019;71:878–91.

    PubMed  PubMed Central  Google Scholar 

  • van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum. 2004;50(3):709–15. https://doi.org/10.1002/art.20044.

    Article  CAS  PubMed  Google Scholar 

  • van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther. 2006;8(5):R151. https://doi.org/10.1186/ar2045.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Verhoef LM, van den Bemt BJ, van der Maas A, Vriezekolk JE, Hulscher ME, van den Hoogen FH, et al. Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity. Cochrane Database Syst Rev. 2019;24:CD010455.

    Google Scholar 

  • Verschueren P, De CD, Corluy L, Joos R, Langenaken C, Taelman V, et al. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial. Ann Rheum Dis. 2015;74(1):27–34.

    CAS  PubMed  Google Scholar 

  • Vigano M, Degasperi E, Aghemo A, Lampertico P, Colombo M. Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management. Expert Opin Biol Ther. 2012;12(2):193–207.

    CAS  PubMed  Google Scholar 

  • Vital EM, Dass S, Rawstron AC, Buch MH, Goeb V, Henshaw K, Ponchel F, Emery P. Management of non-response to rituximab in rheumatoid arthritis: predictors and outcome of retreatment. Arthritis Rheum. 2010;62:1273–9.

    CAS  PubMed  Google Scholar 

  • Wasko MC, Hubert HB, Lingala VB, Elliott JR, Luggen ME, Fries JF, Ward MM. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA. 2007;298(2):187–93.

    CAS  PubMed  Google Scholar 

  • Weinblatt ME. Methotrexate in rheumatoid arthritis: a quarter century of development. Trans Am Clin Climatol Assoc. 2013;124:16–25.

    PubMed  PubMed Central  Google Scholar 

  • Weinblatt M, Schiff M, Goldman A, et al. Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomized clinical trial. Ann Rheum Dis. 2007;66:228–34.

    CAS  PubMed  Google Scholar 

  • Whiting PF, Smidt N, Sterne JA, Harbord R, Burton A, Burke M, et al. Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med. 2010;152(7):456–64; W155–66.

    PubMed  Google Scholar 

  • Xie W, Huang Y, Xiao S, Sun X, Fan Y, Zhang Z. Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials. Ann Rheum Dis. 2019;78:1048–54.

    CAS  PubMed  Google Scholar 

  • Yogasundaram H, Putko BN, Tien J, Paterson DI, Cujec B, Ringrose J, Oudit GY. Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment. Can J Cardiol. 2014;30:1706–15.

    PubMed  Google Scholar 

  • Zaccardelli A, Friedlander HM, Ford JA, Sparks JA. Potential of lifestyle changes for reducing the risk of developing rheumatoid arthritis: is an ounce of prevention worth a pound of cure? Clin Ther. 2019;41(7):1323–45.

    PubMed  PubMed Central  Google Scholar 

  • Zautra AJ, Davis MC, Reich JW, et al. Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J Consult Clin Psychol. 2008;76(3):408–21.

    PubMed  Google Scholar 

  • Zbinden A, van den Brandt S, Ostensen M, et al. Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: disease activity matters. Rheumatology. 2018;57(7):1235–42.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, USA

    Kevin D. Deane, V. Michael Holers, Jason R. Kolfenbach & Duane W. Pearson

  2. Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria

    Daniel Aletaha & Josef Smolen

  3. Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY, USA

    Joan M. Bathon

  4. Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK

    Paul Emery

  5. NIHR Leeds Musculoskeletal Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK

    Paul Emery

  6. Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK

    George E. Fragoulis

  7. Leiden University, Leiden, The Netherlands

    T. W. J. Huizinga

  8. Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA

    James R. O’Dell

  9. Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, USA

    Elizabeth Park

  10. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan

    Yoshiya Tanaka

  11. Botnar Research Centre, University of Oxford, Oxford, UK

    Peter C. Taylor

  12. Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands

    Annette van der Helm-van Mil

  13. Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), Karolinska Institutet, Stockholm, Sweden

    Ronald F. van Vollenhoven

  14. Duke University Medical Center, Durham, NC, USA

    E. William St. Clair

Authors
  1. Kevin D. Deane
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Aletaha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joan M. Bathon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul Emery
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. George E. Fragoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. Michael Holers
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. W. J. Huizinga
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jason R. Kolfenbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. James R. O’Dell
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Duane W. Pearson
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Elizabeth Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Josef Smolen
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Yoshiya Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Peter C. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Annette van der Helm-van Mil
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Ronald F. van Vollenhoven
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. E. William St. Clair
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kevin D. Deane .

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, Harvard University Massachusetts General Hospital, Boston, MA, USA

    John H. Stone

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Deane, K.D. et al. (2023). Rheumatoid Arthritis . In: Stone, J.H. (eds) A Clinician's Pearls & Myths in Rheumatology. Springer, Cham. https://doi.org/10.1007/978-3-031-23488-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-23488-0_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-23487-3

  • Online ISBN: 978-3-031-23488-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation